India set to halve time for drug trial nod, endorse major overseas approvals
Published on: Sept. 4, 2025, 5:30 a.m. | Source: Livemint
The health ministry has proposed new rules to cut drug trial approval time from 90 to 45 days, aiming to boost pharmaceutical innovation and patient access. The changes include a simplified online notification system for drug studies, while maintaining safety norms for high-risk categories.
